Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran.
J Neurosurg. 2013 Aug;119(2):353-61. doi: 10.3171/2013.4.JNS121636. Epub 2013 May 31.
Although there is evidence that estradiol has neuroprotective effects after traumatic brain injury (TBI) in female rats, it is unclear which estrogen receptor (ER) subtype, ERα or ERβ, mediates this effect. The authors therefore examined the roles of the different ERs in this effect. Here the authors used the ERα selective agonist propyl pyrazole triol (PPT) and the ERβ selective agonist diarylpropionitrile (DPN) alone and in combination in female rats to investigate this question.
Before the ovariectomized animals were injured using the Marmarou TBI technique, they were randomly divided into the following 9 groups: control, sham, TBI, vehicle, E1 (physiological dose of 17-β estradiol), E2 (pharmacological dose of 17-β estradiol), PPT, DPN, and PPT+DPN. Levels of blood-brain barrier (BBB) disruption (5 hours) and water content (24 hours) were evaluated after TBI. In groups receiving drugs or vehicle, treatment was administered as a single dose intraperitoneally 30 minutes after induction of TBI.
Results showed that brain edema or brain water content after TBI was lower (p < 0.001) in the E2, PPT, DPN, and PPT+DPN groups than it was in the vehicle group. After trauma, the Evans blue dye content or BBB permeability was significantly higher in the TBI and vehicle groups (p < 0.001) than in the E2, PPT, DPN, and PPT+DPN groups. The inhibitory effects of PPT+DPN on brain water content, neurological scores, and Evans blue dye content were the highest for all groups. Although both PPT and DPN increased neurological scores after TBI, PPT appears to be more effective in increasing neurological scores.
Neuroprotective effects of estradiol on brain edema, BBB permeability, and neurological scores are mediated through both ERα and ERβ. This may suggest a therapeutic potential in the brain trauma for ER-specific agonists.
虽然有证据表明雌二醇(E2)对雌性大鼠创伤性脑损伤(TBI)后具有神经保护作用,但哪种雌激素受体(ER)亚型,即 ERα 或 ERβ,介导了这种作用尚不清楚。因此,作者研究了不同 ER 在这种作用中的作用。在这里,作者使用 ERα 选择性激动剂丙基吡唑三醇(PPT)和 ERβ 选择性激动剂二芳基丙腈(DPN)单独和联合应用于雌性大鼠来研究这个问题。
在使用 Marmarou TBI 技术对去卵巢动物造成损伤之前,将它们随机分为以下 9 组:对照组、假手术组、TBI 组、载体组、E1(17-β 雌二醇的生理剂量)、E2(17-β 雌二醇的药理剂量)、PPT、DPN 和 PPT+DPN。TBI 后 5 小时评估血脑屏障(BBB)通透性(5 小时)和水含量(24 小时)。在接受药物或载体治疗的组中,在 TBI 诱导后 30 分钟给予单次腹腔内给药。
结果表明,与载体组相比,E2、PPT、DPN 和 PPT+DPN 组 TBI 后脑水肿或脑水含量较低(p<0.001)。创伤后,TBI 和载体组的 Evans 蓝染料含量或 BBB 通透性明显高于 E2、PPT、DPN 和 PPT+DPN 组(p<0.001)。与所有组相比,PPT+DPN 对脑水含量、神经评分和 Evans 蓝染料含量的抑制作用最高。虽然 PPT 和 DPN 均可增加 TBI 后的神经评分,但 PPT 似乎更能有效提高神经评分。
E2 对脑水肿、BBB 通透性和神经评分的神经保护作用是通过 ERα 和 ERβ 介导的。这可能表明 ER 特异性激动剂在脑创伤治疗方面具有潜在的治疗作用。